Genes vs environment in inflammatory bowel disease: an update

被引:8
|
作者
Dipasquale, Valeria [1 ]
Romano, Claudio [1 ]
机构
[1] Univ Messina, Pediat Gastroenterol & Cyst Fibrosis Unit, Dept Human Pathol Adulthood & Childhood G Barresi, Via Consolare Valeria 1, I-98124 Messina, Italy
关键词
Environment; gene; inflammatory bowel disease; risk factor; very early onset inflammatory bowel disease; CROHNS-DISEASE; ULCERATIVE-COLITIS; PEDIATRIC GASTROENTEROLOGY; WIDE ASSOCIATION; RECENT INSIGHTS; ACTIVE DISEASE; POSITION PAPER; TWIN COHORT; FOLLOW-UP; RISK;
D O I
10.1080/1744666X.2022.2108407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Inflammatory bowel diseases (IBDs) are known to be caused by a combination of genetic and environmental factors that vary in their influence on the development of the disease. Environmental exposures seem to influence IBD susceptibility, whereas genetic background is thought to modulate the impact of the environment on disease course and phenotype. Areas covered A broad review of the involvement of genes and the environment in IBD pathogenesis was performed, and information regarding the main genetic and environmental factors - categorized into lifestyle factors, drugs, diet, and microbes - was updated. Monogenic very early onset IBD (VEO-IBD) was also discussed. Expert opinion In the upcoming years, better understanding of gene-environment interactions will contribute to the possibility of a better prediction of disease course, response to therapy, and therapy-related adverse events with the final goal of personalized and more efficient patient management.
引用
收藏
页码:1005 / 1013
页数:9
相关论文
共 50 条
  • [21] Update of the management of inflammatory bowel disease
    Fell, J. M. E.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2012, 97 (01) : 78 - 83
  • [22] Update on mesalazine for inflammatory bowel disease
    Hanauer, SB
    IBD AND SALICYLATES - 3, 1998, 20 (01): : 203 - 208
  • [23] Genes, diet and inflammatory bowel disease
    Ferguson, Lynnette R.
    Shelling, Andrew N.
    Browning, Brian L.
    Huebner, Claudia
    Petermann, Ivonne
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2007, 622 (1-2) : 70 - 83
  • [24] Inflammatory bowel disease: Germs or genes?
    Pavli, P
    Cavanaugh, J
    Grimm, M
    LANCET, 1996, 347 (9010): : 1198 - 1198
  • [25] Treatment of inflammatory bowel disease in the elderly - An update
    Pardi, DS
    Loftus, EV
    Camilleri, M
    DRUGS & AGING, 2002, 19 (05) : 355 - 363
  • [26] Update on the genetics of inflammatory bowel disease.
    Cho J.H.
    Current Gastroenterology Reports, 2001, 3 (6) : 458 - 463
  • [27] Use of thiopurines in inflammatory bowel disease: an update
    Singh, Arshdeep
    Mahajan, Ramit
    Kedia, Saurabh
    Dutta, Amit Kumar
    Anand, Abhinav
    Bernstein, Charles N.
    Desai, Devendra
    Pai, C. Ganesh
    Makharia, Govind
    Tevethia, Harsh Vardhan
    Mak, Joyce W. Y.
    Kaur, Kirandeep
    Peddi, Kiran
    Ranjan, Mukesh Kumar
    Arkkila, Perttu
    Kochhar, Rakesh
    Banerjee, Rupa
    Sinha, Saroj Kant
    Ng, Siew Chien
    Hanauer, Stephen
    Verma, Suhang
    Dutta, Usha
    Midha, Vandana
    Mehta, Varun
    Ahuja, Vineet
    Sood, Ajit
    INTESTINAL RESEARCH, 2022, 20 (01) : 11 - 30
  • [28] Pharmacotherapeutical options in inflammatory bowel disease: an update
    Kho, YH
    Pool, MO
    Jansman, FGA
    Harting, JW
    PHARMACY WORLD & SCIENCE, 2001, 23 (01): : 17 - 21
  • [29] Pharmacotherapeutical options in inflammatory bowel disease: an update
    Y.H. Kho
    M. Oudkerk Pool
    F.G.A. Jansman
    J.W. Harting
    Pharmacy World and Science, 2001, 23 : 17 - 21
  • [30] Update on Vaccinating the Patient With Inflammatory Bowel Disease
    Jennifer Coukos
    Francis A. Farraye
    Current Treatment Options in Gastroenterology, 2018, 16 (4) : 548 - 560